The startup has developed a platform that automates the drug compounding process in pharmacies through three-dimensional printing technology, enabling the on-site production of personalized medications. This system enhances treatment efficacy and medication safety while significantly lowering costs for healthcare providers.
Funding
€21.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
STFounders
Product
Problem
Many pharmacies still rely on manual compounding processes, which are time-consuming, prone to human error, and lack standardized quality control, leading to potential inconsistencies in drug dosages and safety risks for patients. This is especially critical for pediatric and other under-served patient populations requiring personalized medications.
Solution
CurifyLabs offers an automated pharmaceutical compounding solution that modernizes the production of personalized medicines. Their system combines a desktop-sized Pharma Printer, GMP-manufactured Excipient Bases, and a Formulation Library with pre-programmed blueprints and quality dossiers. The Pharma Printer dispenses the Excipient Base and API combination into various dosage forms, such as tablets, liquids, films, and suppositories. In-process quality control tools, including raw material identification and mass uniformity checks, ensure accurate and safe compounding. The Formulation Library provides users with stability data, dissolution profiles, batch records, and cleaning protocols, streamlining the compounding process and reducing the risk of errors.
Target Audience
The primary target audience includes hospital pharmacies, retail pharmacies, the pharmaceutical industry, and veterinarians seeking to improve the efficiency, safety, and quality control of their compounding processes.
Features
- Pharma Printer 1: Automates pharmaceutical compounding, dispensing chewable tablets, capsules, suppositories, and liquids.
- GMP-manufactured Excipient Bases: Enable tailored dosing and dosage forms with validated quality dossiers ensuring content uniformity, shelf life, and drug release profiles.
- Formulation Library: Provides pre-programmed blueprints and quality dossiers for each API, including stability data and dissolution profiles.
- In-process quality control: Utilizes raw material identification, mass uniformity of weights, and content uniformity checks for 100% quality-controlled tablets.
- Software solution: Automatically creates digital batch records and offers an intuitive user interface for easy onboarding.
- Validated cleaning protocols: Ensures fast and effective cleaning procedures to prevent cross-contamination between different APIs.
- Capability to dose directly into blisters, molds, or vials.
- ISO 13485 certified quality management system.